Faruqi & Faruqi Reminds XEROX Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 21, 2025 - XRX
Provided By PR Newswire
Last update: Jan 8, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Xerox To Contact Him Directly To Discuss Their Options
Read more at prnewswire.com
